Ortataxel

Ortataxel is a drug used in chemotherapy. As of June 2009, Spectrum Pharmaceuticals has the drug in a Phase 2 clinical trial.

Ortataxel
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ECHA InfoCard100.158.836
Chemical and physical data
FormulaC44H57NO17
Molar mass871.930 g·mol−1
3D model (JSmol)
  (verify)



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.